1-[[4-[2-(3,4-DIHYDRO-7-METHOXY-4,4-DIMETHYL-1,3-DIOXO-2-(1H)-ISOQUINOLINYL)-ETHYL]-PHENYL]-SULFONYL]-3-(CIS-4-HYDROXYCYCLOHEXYL)-UREA
Compound with spectra: 1 NMR
![1-[[4-[2-(3,4-DIHYDRO-7-METHOXY-4,4-DIMETHYL-1,3-DIOXO-2-(1H)-ISOQUINOLINYL)-ETHYL]-PHENYL]-SULFONYL]-3-(CIS-4-HYDROXYCYCLOHEXYL)-UREA](/api/compound/B0TiYtaUw2u.png?ph=true&h=300&w=458 "1-[[4-[2-(3,4-DIHYDRO-7-METHOXY-4,4-DIMETHYL-1,3-DIOXO-2-(1H)-ISOQUINOLINYL)-ETHYL]-PHENYL]-SULFONYL]-3-(CIS-4-HYDROXYCYCLOHEXYL)-UREA")
| SpectraBase Compound ID | B0TiYtaUw2u |
|---|---|
| InChI | InChI=1S/C27H33N3O7S/c1-27(2)23-13-10-20(37-3)16-22(23)24(32)30(25(27)33)15-14-17-4-11-21(12-5-17)38(35,36)29-26(34)28-18-6-8-19(31)9-7-18/h4-5,10-13,16,18-19,31H,6-9,14-15H2,1-3H3,(H2,28,29,34)/t18-,19+ |
| InChIKey | HQTIPOUQTNKDNA-KDURUIRLSA-N |
| Mol Weight | 543.6 g/mol |
| Molecular Formula | C27H33N3O7S |
| Exact Mass | 543.203922 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
Gliquidone
N,N-Diethyl-4-hydroxy-2-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide
3,4-dihydro-4,4-dimethyl-3-oxo-1-phenyl-2(1H)isoquinolinecarboxanilide
2,9,10-trimethoxy-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-4-one
4-Benzyl-4-hydroxy-2-methyl-4H-isoquinoline-1,3-dione
1,3(2H,4H)-isoquinolinedione, 4-[[(2,3-dimethylphenyl)amino]methylene]-2-phenyl-, (4E)-
1,3(2H,4H)-isoquinolinedione, 2-(4-methoxyphenyl)-4-[[(2-methylphenyl)amino]methylene]-, (4E)-
1,3-dimethyl-6-[(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)sulfonyl]-2,4(1H,3H)-quinazolinedione
1-(2-methylbenzyl)-3-[2-(3-methylphenyl)ethyl]-2,4(1H,3H)-quinazolinedione
2-(3,4-Methylenedioxyphenyl)butan-1-amine 2PFP II
| Title | Journal or Book | Year |
|---|---|---|
| Hydroxyl-Substituted sulfonylureas as potent inhibitors of specific [3H]Glyburide binding to rat brain synaptosomes | Bioorganic & Medicinal Chemistry | 2003 |